Channel Therapeutics Announces Positive Efficacy Data For a Depot Formulation of a NaV1.7 Inhibitor in a Preclinical In Vivo Nerve Block Model [Yahoo! Finance]
DHI Group, Inc. (DHX)
Last dhi group, inc. earnings: 2/5 04:15 pm
Check Earnings Report
US:NYSE Investor Relations:
dhigroupinc.com/investors/default.aspx
Company Research
Source: Yahoo! Finance
Results are expected for the studies conducted on the Company's eye drops for the treatment of various types of eye pain – including severe dry eye, corneal abrasions, surgical intervention and other indications – in late January 2025. Was this helpful? Yes No What are the results of the thermal hyperalgesia test and mechanical allodynia test conducted by Channel Therapeutics? The results of the thermal hyperalgesia test showed that three of the four formulations of the Company's molecule showed materially better efficacy than bupivacaine, with each of the three being statistically superior to placebo for more than two days longer than bupivacaine. Similarly, the mechanical allodynia test results showed that three of the four formulations showed statistically better efficacy for a longer duration of time than bupivacaine. Was this helpful? Yes No What is the potential benefit of Channel Therapeutics' NaV1.7 inhibitors over existing postoperative therapeutic options?
Show less
Read more
Impact Snapshot
Event Time:
DHX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
DHX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
DHX alerts
High impacting DHI Group, Inc. news events
Weekly update
A roundup of the hottest topics
DHX
News
- DHI Group to Participate in the iAccess Alpha Virtual Best Ideas Winter Conference 2024 on December 10-11, 2024 [Yahoo! Finance]Yahoo! Finance
- DHI Group to Participate in the iAccess Alpha Virtual Best Ideas Winter Conference 2024 on December 10-11, 2024Business Wire
- ClearanceJobs Recognized by White House for Commitment to Skills-Based Hiring in Cybersecurity [Yahoo! Finance]Yahoo! Finance
- ClearanceJobs Recognized by White House for Commitment to Skills-Based Hiring in CybersecurityBusiness Wire
- DHI Group, Inc. (NYSE: DHX) had its "outperform" rating re-affirmed by analysts at Barrington Research. They now have a $7.00 price target on the stock.MarketBeat
DHX
Earnings
- 11/12/24 - Beat
DHX
Sec Filings
- 12/20/24 - Form 4
- 12/19/24 - Form 144
- 12/2/24 - Form 4
- DHX's page on the SEC website